Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. 1996

S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
Department of Infectious Disease, The Cleveland Clinic Foundation, Ohio 44195, USA.

To assess the impact of the antiseptic effects of silver sulfadiazine-chlorhexidine-impregnated central venous catheters on catheter culture systems, a series of in vitro experiments was performed. Segments of antiseptic and non-antiseptic-impregnated catheters were sonicated in thioglycolate broth and removed. After the addition of 10(3) CFU of Staphylococcus epidermidis per ml, aliquots of catheter-exposed broth were subcultured onto blood agar at 15-min intervals. Decreased mean colony counts were noted at 45 min for broth exposed to antiseptic-impregnated catheters compared with the colony counts for broth exposed to non-antiseptic-impregnated catheters (170 versus 540 CFU/ml). These effects, which were also demonstrated by the roll-plate method, were abrogated by the use of medium containing inhibitors of silver sulfadiazine and chlorhexidine. To assess the duration of the antiseptic effects, catheter segments were suspended for up to 14 days in phosphate-buffered saline, incubated with 10(6) CFU of S. epidermidis per ml, and cultured. Inhibition of bacterial growth by antiseptic-impregnated catheters disappeared after 14 days. These studies suggest that antiseptic compounds elute from catheters during broth- and solid medium-based culturing processes, making necessary the addition of inhibitors of these compounds in culture media. They further suggest that the antimicrobial effects of antiseptic-impregnated catheters wane within several days of placement.

UI MeSH Term Description Entries
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D002710 Chlorhexidine A disinfectant and topical anti-infective agent used also as mouthwash to prevent oral plaque. Chlorhexidine Acetate,Chlorhexidine Hydrochloride,MK-412A,Novalsan,Sebidin A,Tubulicid,Acetate, Chlorhexidine,Hydrochloride, Chlorhexidine,MK 412A,MK412A
D000891 Anti-Infective Agents, Local Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. Anti-Infective Agents, Topical,Antiseptic,Antiseptics,Microbicides, Local,Microbicides, Topical,Antiinfective Agents, Local,Antiinfective Agents, Topical,Local Anti-Infective Agents,Local Antiinfective Agents,Topical Anti-Infective Agents,Topical Antiinfective Agents,Agents, Local Anti-Infective,Agents, Local Antiinfective,Agents, Topical Anti-Infective,Agents, Topical Antiinfective,Anti Infective Agents, Local,Anti Infective Agents, Topical,Local Anti Infective Agents,Local Microbicides,Topical Anti Infective Agents,Topical Microbicides
D012837 Silver Sulfadiazine Antibacterial used topically in burn therapy. Brandiazin,Dermazin,Flamazine,Flammazine,SSD,SSD AF,Sicazine,Silvadene,Silvederma,Sulfafdiazine, Silver,Sulfargen,Thermazene,Silver Sulfafdiazine,Sulfadiazine, Silver
D013212 Staphylococcus epidermidis A species of STAPHYLOCOCCUS that is a spherical, non-motile, gram-positive, chemoorganotrophic, facultative anaerobe. Mainly found on the skin and mucous membrane of warm-blooded animals, it can be primary pathogen or secondary invader.
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
October 1996, Journal of clinical microbiology,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
April 2012, The new microbiologica,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
March 2014, American journal of infection control,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
October 2015, Journal of the American College of Surgeons,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
May 1998, Masui. The Japanese journal of anesthesiology,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
July 2015, American journal of infection control,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
May 1995, Critical care medicine,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
October 2014, American journal of infection control,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
January 2016, American journal of infection control,
S K Schmitt, and C Knapp, and G S Hall, and D L Longworth, and J T McMahon, and J A Washington
December 2004, American journal of infection control,
Copied contents to your clipboard!